Expertise

Market Access and HEOR

Navigating Complexity. Unlocking Value. Expanding Access.

At Herspiegel, we help pharmaceutical, and biotech companies secure timely, optimal market access by guiding them through the most decisive moments powering commercial success and expanding patient access. From early-stage development through launch and beyond, we ensure products are positioned for success—backed by evidence, aligned across functions, and communicated with clarity.

Our integrated team combines scientific strategy, market insights, rigorous evidence and outcomes research with precise execution. This approach helps you navigate complex payer landscapes, overcome access barriers, and deliver value where it matters most: to patients.

Comprehensive Market Access Strategy and Execution

We partner with clients to:

Uncover Insights Understand the patient journey, treatment landscape, and barriers to access—informing a compelling target product profile (TPP) and differentiated value strategy.
Establish Evidence-Based ValueBuild technically robust HEOR evidence strategies – including gap analyses, health economic models, indirect treatment comparisons, systematic literature reviews and cost of illness studies – and prepare for, and execute, global, regional and local HTA and HEOR reimbursement submissions.
Develop and Align Strategy Align cross-functional teams across medical affairs, access, commercial, and regulatory functions around an integrated strategy that supports pricing, coverage, and reimbursement goals.
Communicate Value Effectively Translate complex science into impactful value stories for diverse stakeholders—including payers, HTA bodies, providers, and patients.
Execute Seamlessly From coverage and coding to pull-through strategies and field team coordination, we ensure the final mile of market access is executed with precision.

Our agile team structure allows for swift, seamless project execution, free from unnecessary bureaucracy. This practical agility and technical expertise, combined with out-of-the-box strategic thinking, ensures we deliver the compelling economic and patient-centric evidence-backed strategy to guide you through your most decisive moments to maximize market access and commercial success.

Global Reach. Proven Impact.

Experience in 40+ countries
HTA leadership in 20+ global markets, with success in orphan indications through to crowded oncology markets
100+ health economic models developed across 20+ countries, in 40+ indications
Operational presence in the US, UK, Germany, Poland, and Canada

Meet the Experts

Jay Jackson, PharmD, MPH, BCMAS is a partner at Herspiegel and an experienced market access professional within the biopharmaceutical, medical device, and digital therapeutics industry. For more than 20 years, Jay has partnered with US and global clients of varying sizes and product portfolios to provide value-driven solutions that demonstrate brand value and maximize patient access to therapies. He has experience across multiple therapeutic areas, including oncology, cardiovascular, respiratory, autoimmune, infectious disease, central nervous system disorders, and rare diseases. He received his Doctor of Pharmacy degree from the Mercer University Southern School of Pharmacy and a Master of Public Health in Epidemiology from the University of South Florida College of Public Health. He also has postdoctoral training that includes the completion of an Outcomes Research Fellowship and a Board Certification in Medical Affairs.

Solutions

Market Access

JCA Lab

JCA Lab helps organizations get ready for Joint Clinical Assessment with end-to-end delivery and support. Read here.

Market Access

PICO Predict

Expert-led, AI-enabled approach to help navigate the PICO maze for a successful JCA. Read here.

Market Access

High-Quality Economic Models

We deliver high-quality economic models by tailoring our approach to each client's unique needs. Read here.

Market Access

HTA Submissions and Regulatory Support

We have extensive experience delivering successful HTA submissions across the globe. Read here.

Market Access

Pricing, Coverage, and Reimbursement Strategy

We develop strategies for global pricing and reimbursement, harnessing our extensive KOL and payer network across the globe. Read here.

Market Access

Value Communication and Global Value Dossiers

We clearly and impactfully communicate product value, from global dossiers to scientific publications. Read here.

Market Access

NMA Builder: Accelerated, Transparent Network Meta-Analysis

Run complex network meta-analyses in a fraction of the time with our intuitive, efficient NMA Builder. Read here.

Market Access

Survival Analysis Generator: Rapid, Reliable Survival Curve Modeling

Run Accurate Survival Analyses with Speed and Confidence. Read here.

Market Access

Model Builder: Streamline Health Economic Model Development with Confidence

Our Model Builder is an online platform, enabling you to develop Excel-based economic models at a global or local level, early or late-stage. Read here.

Market Access

Strategic Market Access Insights That Strengthen Coverage and Accelerate Access

Herspiegel’s Strategic Market Access Insights Service empowers pharmaceutical manufacturers with the clarity to navigate the evolving access environment with confidence. Read here.

Add more content

Add Your Heading Text Here

Resources

Rare Disease Launch: Best Practices – Planning, Budget & Timing

The video outlines best planning, timing, and budgeting practices in rare disease product launches. Watch here.

Rare Disease Product Launch: Parameters for Success

The video outlines key success factors in rare disease markets through the five P's: People, Product, Payers, Promotion, and Placement. Watch here.

Market Access

Value-Based Contracting Strategy and Playbook

We helped our major pharmaceutical client equip it organization to offer value-based contracts to support access for a new specialty drug. Read the case study.

Market Access

Communicating Value to Payers for New Auto-Immune Product

We helped a biopharma company design a compelling payer value story presentation for its new auto-immune product

Market Access

Economic Model Quantifying Rx to OTC Availability

We partnered with our client to establish a narrative that increased availability results in improvements in health outcomes and downstream cost savings. Read the case

Market Access

Pre-approval Information Exchange Playbook

Discover how to tailor product launches effectively with our Archetype Playbook. Master your market strategy now.

Case Studies

Market Access

Reimbursement Strategy for Ophthalmic Insert

Discover how our tailored reimbursement strategy propelled a small biotech's innovative ophthalmic product to exceed launch forecasts by 60% in patient treatment.

Market Access

Economic Model Quantifying Rx to OTC Availability

We partnered with our client to establish a narrative that increased availability results in improvements in health outcomes and downstream cost savings. Read the case study.

Market Access

Evidence Generation Strategy – Cystic Fibrosis Asset/COPD

We helped a client’s new product team plan their US and EU access strategies for a novel compound with potential in both rare and more common respiratory conditions. Read the

Market Access

Evidence Generation Strategy for a New Drug Formulation

A global pharmaceutical company worked with us to plan their European Union (EU) access strategy for a novel oncolytic drug based on a new formulation. Read the case study.

Market Access

Payer Value Proposition Development in a Crowded Disease Space

Our client, a mid-sized biopharmaceutical company, aimed to introduce a new asset into the highly competitive Parkinson's disease category. Read the case study.

Let's Talk

Name(Required)

Email(Required)

Phone

Message